CD8A and myasthenia gravis: In patients with MG with MuSK, tacrolimus inhibited CD8+ T-cell proliferation and interferon (IFN)-γ and IL-2 production; however, tacrolimus inhibition was lower in CD4+ T cells [58, 59].